Thompson Siegel & Walmsley LLC Trims Stock Position in Koninklijke Philips (NYSE:PHG)

Thompson Siegel & Walmsley LLC lessened its stake in Koninklijke Philips (NYSE:PHG - Free Report) by 13.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,679,033 shares of the technology company's stock after selling 254,986 shares during the period. Thompson Siegel & Walmsley LLC owned 0.18% of Koninklijke Philips worth $54,938,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in PHG. Dimensional Fund Advisors LP grew its position in shares of Koninklijke Philips by 27.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,036,336 shares of the technology company's stock worth $101,718,000 after buying an additional 864,951 shares during the last quarter. Millennium Management LLC increased its position in shares of Koninklijke Philips by 822.0% during the second quarter. Millennium Management LLC now owns 1,120,521 shares of the technology company's stock worth $28,237,000 after purchasing an additional 998,995 shares in the last quarter. Natixis Advisors LLC lifted its holdings in shares of Koninklijke Philips by 5.2% during the 2nd quarter. Natixis Advisors LLC now owns 930,085 shares of the technology company's stock valued at $23,438,000 after purchasing an additional 46,268 shares during the last quarter. Jane Street Group LLC boosted its position in shares of Koninklijke Philips by 361.7% in the 1st quarter. Jane Street Group LLC now owns 629,136 shares of the technology company's stock worth $12,583,000 after purchasing an additional 492,881 shares in the last quarter. Finally, London & Capital Asset Management Ltd grew its stake in Koninklijke Philips by 12.1% during the 1st quarter. London & Capital Asset Management Ltd now owns 581,993 shares of the technology company's stock worth $11,640,000 after buying an additional 62,656 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have commented on PHG. Jefferies Financial Group upgraded Koninklijke Philips from an "underperform" rating to a "hold" rating in a research note on Tuesday, October 29th. StockNews.com lowered shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Thursday, November 14th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold".

Koninklijke Philips Stock Up 0.3 %

Shares of NYSE PHG traded up $0.07 during mid-day trading on Thursday, hitting $26.38. The stock had a trading volume of 553,234 shares, compared to its average volume of 968,033. The company has a 50 day moving average of $29.81 and a two-hundred day moving average of $28.27. Koninklijke Philips has a twelve month low of $19.49 and a twelve month high of $32.91. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.